Galia Rahav

Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial

Richard G. Wunderink, Evangelos J. Giamarellos‐Bourboulis, Galia Rahav et al. · Infectious Diseases and Therapy · 2018 · 442 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Potential Role of Active Surveillance in the Control of a Hospital-Wide Outbreak of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Infection

Debby Ben-David, ‪Yasmin Maor‬‏, Nathan Keller et al. · Infection Control and Hospital Epidemiology · 2010 · 170 citations

Life Sciences, Infectious Diseases, Microbiology +17

National Multicenter Study of Predictors and Outcomes of Bacteremia upon Hospital Admission Caused by <i>Enterobacteriaceae</i> Producing Extended-Spectrum β-Lactamases

Dror Marchaim, Tamar Gottesman, Orna Schwartz et al. · Antimicrobial Agents and Chemotherapy · 2010 · 143 citations

Life Sciences, Infectious Diseases, Microbiology +14

Rapid Detection of <i>bla</i> _KPC Carbapenemase Genes by Real-Time PCR

Musa Hindiyeh, Gill Smollen, Zehava Grossman et al. · Journal of Clinical Microbiology · 2008 · 127 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17